Glioblastoma Targeted Treatment Option Maximization by WGS

NARecruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

July 25, 2022

Primary Completion Date

July 1, 2024

Study Completion Date

July 1, 2025

Conditions
Glioblastoma
Interventions
DIAGNOSTIC_TEST

whole genome sequencing

whole genome sequencing will be performed on tumor material after re-resection per standard of care

Trial Locations (1)

Unknown

RECRUITING

Haaglanden Medisch Centrum, The Hague

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Amsterdam University Medical Center

OTHER

collaborator

The Netherlands Cancer Institute

OTHER

collaborator

The Elisabeth-TweeSteden Hospital

OTHER

collaborator

Erasmus Medical Center

OTHER

collaborator

Medical Center Haaglanden

OTHER

collaborator

Isala

OTHER

collaborator

Leiden University Medical Center

OTHER

collaborator

Maastricht University Medical Center

OTHER

collaborator

Medisch Spectrum Twente

OTHER

collaborator

Radboud University Medical Center

OTHER

collaborator

University Medical Center Groningen

OTHER

lead

UMC Utrecht

OTHER